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Determination of antimicrobial susceptibility of bovine mastitis pathogens is import-
ant for guiding antimicrobial treatment decisions and for the detection of emerging 
resistance. Environmental streptococci are ubiquitous in the farm environment and 
are a frequent cause of mastitis in dairy cows. The aim of the study was to determine 
patterns of antimicrobial susceptibility among species of environmental streptococci 
isolated from dairy cows in the Maritime Provinces of Canada. The collection con-
sisted of 192 isolates identified in milk samples collected from 177 cows originating 
from 18 dairy herds. Results were aggregated into: (1) Streptococcus uberis (n = 70), 
(2) Streptococcus dysgalactiae (n =  28), (3) other Streptococci spp. (n =  35), (4), 
Lactococcus spp. (n = 32), and (5) Enterococcus spp. (n = 27). Minimum inhibitory 
concentrations (MICs) were determined using the Sensititre microdilution system and 
mastitis plate format. Multilevel logistic regression models were used to analyze the 
data, with antimicrobial susceptibility as the outcome. The proportion of susceptible 
S. uberis ranged from 23% (for penicillin) to 99% (for penicillin/novobiocin), with a 
median of 82%. All S. dysgalactiae were susceptible to all antimicrobials except for 
penicillin (93% susceptible) and tetracycline (18% susceptible). The range of sus-
ceptibility for other Streptococcus spp. was 43% (for tetracycline) to 100%, with a 
median percent susceptibility of 92%. Lactococcus spp. isolates displayed percent 
susceptibilities ranging from 0% (for penicillin) to 97% (for erythromycin), median 75%. 
For the antimicrobials tested, the minimum inhibitory concentrations were higher for 
Enterococcus spp. than for the other species. According to the multilevel models, 
there was a significant interaction between antimicrobial and bacterial species, indi-
cating that susceptibility against a particular antimicrobial varied among the species 
of environmental streptococci and vice versa. Generally, susceptibility decreased with 
increasing within-herd average somatic cell count, isolates recovered in mid-lactation 
were more susceptible than isolates recovered in early lactation, and isolates recov-
ered in samples collected post-clinical mastitis were more susceptible than isolates 
recovered from non-clinical lactating quarters. The results of this research support 
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continued susceptibility of environmental streptococci to beta-lactam antimicrobials. A 
departure from the expected susceptibility to beta-lactams was the apparent reduced 
susceptibility of S. uberis to penicillin.
Keywords: Streptococcus uberis, Streptococcus dysgalactiae, environmental streptococci, antimicrobial 
susceptibility, bovine, intramammary infection
inTrODUcTiOn
Mastitis in dairy cows is a prevalent and costly disease for the dairy 
industry (1). Treatment and prevention of mastitis represents the 
most common reason for antimicrobial use on dairy farms (2, 3). 
Determination of antimicrobial susceptibility patterns of bovine 
mastitis pathogens is important for guiding antimicrobial treat-
ment decisions and for the early detection of emerging antimicro-
bial resistance (AMR) among different bacterial species. The role 
of livestock as a potential source of AMR bacteria or resistance 
genes is a growing concern (4); therefore, surveillance of AMR in 
food-producing animals is important from both animal health 
and human health perspectives.
Environmental streptococci, including Streptococcus uberis 
(S. uberis), Streptococcus dysgalactiae (S. dysgalactiae), and 
Enterococcus spp., are ubiquitous in the farm environment and 
are a frequent cause of both clinical and subclinical mastitis in 
dairy cows (5–7). While traditionally classified as environmental 
pathogens, with the source of the causative pathogen being 
the environment in which the cow lives, both S. uberis and S. 
dysgalactiae have been shown to be occasional agents of con-
tagious mastitis, transmitted from cow-to-cow via the milking 
process (8, 9). In large part, previous reports on the antimicrobial 
susceptibility of environmental streptococci (most commonly 
S. uberis and S. dysgalactiae) do not indicate widespread emerg-
ing resistance, despite a long history of exposure to antimicrobial 
treatments (10–12). However, also present within the literature 
are occasional reports of reduced susceptibility of S. uberis to 
penicillin (13–15). Considering that penicillin and other beta-
lactams are considered to be the first-line of defense against 
streptococci, as well as the potential for transfer of resistance 
determinants between species (16), continued surveillance for 
AMR among field isolates of S. uberis and other environmental 
streptococci is warranted.
A lesser known genus among the large group of environmental 
streptococci bacteria are the Lactococcus spp. Historically, tradi-
tional biochemical identification methods have been unreliable 
for Lactococcus spp. and as a result, their importance in bovine 
mastitis is not well-understood (7). Similarly, reports of the 
antimicrobial susceptibility profiles of Lactococcus spp. are sparse. 
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight 
Mass Spectrometry (MALDI-ToF MS) is a powerful instrument 
capable of accurately identifying thousands of bacteria, including 
Lactococcus spp. (17, 18). This diagnostic tool generates protein 
spectral fingerprints of unknown samples and compares them 
to a database of reference spectra in order to derive identifica-
tion. Application of advanced diagnostic methodologies, such 
as MALDI-ToF MS, on a routine basis, will help to expand our 
understanding of clinical importance of Lactococcus spp.
While recent investigations have described the AMR profiles of 
Staphylococcus aureus (S. aureus), Klebsiella spp., and Escherichia 
coli (E. coli) isolated on Canadian dairy farms (19), the suscep-
tibility profiles of environmental streptococci associated with 
bovine intramammary infection (IMI) in Canada have not been 
well defined. The aim of the current study was to determine the 
patterns of antimicrobial susceptibility among different species 
of environmental streptococci isolated in milk samples collected 
from dairy cows in the Maritime Provinces of Canada.
MaTerials anD MeThODs
source of isolates
Isolates for this study were obtained from the Mastitis Pathogen 
Culture Collection (MPCC) of the Canadian Bovine Mastitis and 
Milk Quality Research Network (CBMQRN). Isolates within the 
MPCC were recovered in milk samples collected during a 2-year 
(2007 and 2008) longitudinal cohort study involving 91 com-
mercial dairy herds from six Canadian provinces. Details of herd 
selection and sample collection for the cohort study have been 
described by Reyher et al. (5). Regarding milk sample collection, 
three sampling series were targeted within the cohort study: (1) 
longitudinally collected lactational samples from healthy cows 
(lactational series), (2) samples collected from quarters with 
clinical mastitis on the day of diagnosis and repeated at 2–3 weeks 
and 4–5 weeks post-diagnosis (clinical series), and (3) samples 
collected from cows before the end of lactation and post-calving 
(dry period series). For lactational and dry period series, both 
quarter and composite samples were collected; for the clinical 
series, only the affected quarter was sampled.
selection of isolates
The isolates selected for the current study were identified as 
S.  uberis, S. dysgalactiae, or other Streptococci species within 
the MPCC and all isolates originated from herds located in the 
Maritime Provinces. According to the CBMQRN cohort study 
database, a total of 241 S. uberis, 107 S. dysgalactiae, and 377 other 
Streptococci spp. were available. Budgetary limits dictated that 
approximately 300 isolates could be examined for antimicrobial 
susceptibility. Isolates were selected to target a maximum of 
one species type (S. uberis, S. dysgalactiae, or other Streptococci 
species) per quarter (or composite sample) per sampling series 
(lactational, clinical, or dry period). The final collection of 
isolates comprised 75 S. uberis, 36 S. dysgalactiae, and 185 other 
Streptococci species previously identified in 296 milk samples 
collected from 243 cows originating from 18 dairy herds. Over 
half of the isolates (147/296) were recovered in lactational series 
samples, 63 were isolated 2–4 weeks after a documented case of 
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clinical mastitis, and 86 were identified in dry period samples (28 
at dry off; 58 post-calving).
antimicrobial Use
In an associated study involving 17 out of the 18 farms over 
the same time period, antimicrobial use was estimated using a 
garbage can audit method (3). With regards to intramammary 
treatments, a penicillin-based therapy was used most frequently 
in the treatment of clinical mastitis (94% of the herds), followed 
by a first generation cephalosporin (cephapirin). All 17 herds 
reported using intramammary antimicrobial treatment at the 
end of lactation, the majority of which consisted of penicillin-
based products (94% of the herds). With regards to systemic 
treatments, the most commonly used class were third generation 
cephalosporins, followed by penicillins [both used in 94% of the 
herds; Ref. (3)].
Bacteriology
The isolates were transferred from the MPCC (Université 
de Montréal, Saint-Hyacinthe, QC, Canada) to the Atlantic 
Veterinary College (Charlottetown, PE, Canada) in lyophilized 
form. To re-vive the isolates, 1.0 mL of tryptic soy broth was added 
to each lyophilized culture. The inoculum was applied to a half 
plate of blood agar using a sterile swab and was streaked using a 
sterile disposable loop. Plates were incubated for 18–24 h at 35°C 
and observed for pure growth. Single colonies were sub-cultured 
onto blood agar and incubated for 18–24 h at 35°C.
MalDi-ToF Mass spectrometry 
identification
All isolates were characterized using the Bruker microflex 
MALDI-ToF MS system and Biotyper 3.0 software (Bruker 
Daltonik GmbH, Bremen, Germany). Samples were analyzed in 
duplicate using the direct transfer method as follows: bacterial 
cells from a single colony were transferred onto a stainless steel 
target, the spot was air dried at ambient temperature, was overlaid 
with 1  μl matrix HCCA (α-cyano-4-hydroxy-cinnamic acid) 
diluted in a solution of 50% acetonitrile and 2.5% trifluoroacetic 
acid, and allowed to air dry a second time at ambient temperature. 
The target plate was subsequently introduced into the microflex 
MALDI-ToF mass spectrometer for automated measurement of 
mass spectra and comparison to the reference database (Biotyper 
v3.0). Identifications scores ≥2.0 were required for confident 
species identification; scores <2.0 and ≥1.7 were considered 
confident genus identification; isolates with scores <1.7 were 
 re-analyzed in duplicate, and if they failed to achieve a score ≥1.7 
on the second round, they were classified as unidentified.
Determination of antimicrobial 
susceptibility
Antimicrobial susceptibility was determined using the Sensititre 
microdilution system and mastitis plate format CMV1AMAF 
(Trek Diagnostic Systems Inc., Cleveland, OH, USA). The masti-
tis plate contained twofold serial dilutions of the following anti-
microbials: ampicillin (0.125–8 μg/mL), ceftiofur (0.5–4 μg/mL), 
cephalothin (2– 6 μg/mL), erythromycin (0.25–4 μg/mL), oxacil-
lin (2–4 μg/mL), penicillin (0.125–8 μg/mL), penicillin/novo-
biocin combination (1/2–8/16 μg/mL), pirlimycin (0.5–4 μg/mL), 
sulfadimethoxine (32–256  μg/mL), and tetracycline (1–8  μg/
mL). Pure subcultures were used to make bacterial suspensions 
that were standardized to a 0.5 McFarland turbidity standard 
as per manufacturer instructions. For Streptococci spp., 100 μL 
of suspension was delivered to each well; for species other than 
Streptococcus genus, 50 μL was dispensed (20). Subcultures were 
taken from the suspensions and plated on Columbia agar with 5% 
sheep blood to confirm purity. The mastitis plates were incubated 
aerobically at 35°C for 18–24 h (20–24 h for Streptococci spp.) 
and were subsequently read automatically using the Sensititre 
ARIS® (Trek Diagnostic Systems Inc., Cleveland, OH, USA). In 
case of an error message, the plates were read manually using 
the Sensititre Vizion System® (Trek Diagnostic Systems Inc., 
Cleveland, OH, USA). Quality control in accordance with 
the Clinical Laboratory and Standards Institute (CLSI) using 
S. aureus ATCC 29213 and E. coli ATCC 25922 was performed 
for each new lot of plates (20).
Aerococcus viridans is generally considered apathogenic (21); 
therefore, only Aerococcus spp. isolates recovered in samples 
that had an somatic cell count (SCC) > 200,000 cells/mL were 
subjected to minimum inhibitory concentration (MIC) determi-
nation. Also, omitted from susceptibility testing were bacterial 
isolates other than streptococci and isolates without MALDI-ToF 
identification. When the same bacterial species was recovered 
more than once in the same cow, only one isolate per cow was 
considered. Isolates originating from post-mastitis samples were 
preferentially chosen; otherwise, the single isolate within a cow 
was chosen by random selection using Microsoft Excel’s (Excel 
2010, Microsoft Corporation) random number generator.
Isolates identified as resistant to erythromycin and sensitive to 
pirlimycin were tested for inducible lincosamide resistance using 
the D-test (22). Briefly, erythromycin (15 μg) disk was placed at 
a distance of 15 mm (edge to edge) from clindamycin (2 μg) disk 
on a Mueller–Hinton agar plate, previously inoculated with 0.5 
McFarland standard bacterial suspensions. Following overnight 
incubation at 37°C, flattening of zone (D-shaped) around clin-
damycin in the area between the two disks, indicated inducible 
clindamycin resistance.
Data analysis
The MIC was defined as the lowest concentration of antibiotic 
that inhibited bacterial growth. If growth was not inhibited at the 
highest antimicrobial concentration, the isolate was considered 
to be inhibited at the next highest twofold dilution. Enterococcus 
spp. are considered intrinsically resistant to cephalosporins, 
erythromycin, and pirlimycin; therefore, no MICs were reported 
for these bacteria–antimicrobial combinations. Also excluded 
were the MICs for oxacillin and sulfadimethoxine. Oxacillin is 
included in the commercial plate to test for methicillin resist-
ant S. aureus, which was not of interest in the current study; 
sulfadimethoxine is rarely used for the treatment and control 
of mastitis, and the Sensititre manufacturer’s instructions for 
interpretation of the sulfadimethoxine MIC state that they must 
be manually read, which was not done. Using guidelines provided 
TaBle 1 | identification of 296 isolates of environmental streptococci 
recovered from bovine milk samples using matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry.
number % of total
species levela
Streptococcus uberis 80 27.0
Aerococcus viridans 62 21.0
Streptococcus dysgalactiae 34 11.5
Enterococcus faecalis 20 6.8
Lactococcus garvieae 18 6.1
Lactococcus lactis 14 4.7
Enterococcus saccharolyticus 8 2.7
Streptococcus parauberis 6 2.0
Streptococcus gallolyticus 4 1.4
Enterococcus faecium 3 1.0
Enterococcus pseudoavium 3 1.0
Streptococcus cristatus 1 0.3
Streptococcus parasanguinis 1 0.3
Enterococcus avium 1 0.3
Enterococcus casseliflavus 1 0.3
Enterococcus hirae 1 0.3
Enterococcus villorum 1 0.3
Arcanobacterium pluranimalium 1 0.3
Staphylococcus chromogenes 1 0.3
genus levelb
Aerococcus spp. 11 3.7
Streptococcus spp. 5 1.7
Lactococcus spp. 1 0.3
low discriminationc
Streptococcus lutetiensis/equinis 7 2.4
Streptococcus dysgalactiae/canis 4 1.4
Streptococcus gallolyticus/alactolyticus 1 0.3
Streptococcus gallolyticus/lutetiensis 1 0.3
Streptococcus pneumonia/mitis 1 0.3
no identificationd 5 1.7
Total 296 100
aIdentification score ≥2.0; considered secure species identification.
bIdentification score ≥1.7 and <2.0; considered secure genus identification.
cIdentification score ≥2.0 for two different Streptococci species; therefore, only genus 
level classification was possible.
dIdentification score <1.7; considered no reliable identification.
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by the CLSI (20, 23), isolates were categorized as susceptible, 
intermediate, or resistant to each antimicrobial.
statistical analysis
Frequency distributions of MIC, the MIC50, and MIC90 were cal-
culated for each antimicrobial–species combination. Multilevel 
logistic regression models with herd and isolate as random effects 
were used to analyze the data, considering antimicrobial suscep-
tibility as the outcome. Two separate models were constructed, 
one without Enterococcus spp. and one with Enterococcus spp. 
but without the antimicrobials to which Enterococcus spp. are 
considered intrinsically resistant. In the models, the event 
of interest (antimicrobial susceptibility) was coded zero for 
resistant/intermediate and one for susceptible isolates. The 
main predictors were antimicrobial type, bacterial species, and 
an interaction between antimicrobial and bacterial species. 
Additional independent variables examined included a categori-
cal variable for stage of lactation at the time of sample collection 
consisting of early [0–100  days in milk (DIM)], mid (101–200 
DIM), and late (201+ DIM); parity categorized as 1st, 2nd, and 
≥3rd; lactating herd size dichotomized as ≤80 cows and >80 
cows; average within-herd SCC (1,000 cells/mL) categorized as 
low (≤150), moderate (>150 to ≤250), and high (>250); average 
within-herd 24 h milk yield (in kilogram) dichotomized into ≤31 
and >31; average within-herd DIM dichotomized into ≤170 and 
>170. Within-herd averages were calculated using data collected 
by the regional Dairy Herd Improvement agency over the course 
of the study period (2007 and 2008). In the models described 
above, sample type was considered to be an intervening variable 
and, therefore, removed from the models. In temporal terms, the 
quarter became infected with the bacteria prior to sample col-
lection; therefore, sample type would intervene in the pathway 
between bacterial species and antimicrobial susceptibility. Thus, a 
third random effects logistic model for sample type was also con-
sidered. In this model, sample type was categorized as clinically 
healthy lactational (including all isolates recovered in lactational 
and pre-dry-off samples), post-calving (collected between 0 and 
14 DIM), and post-clinical mastitis (collected between 2 and 
5 weeks after a recorded clinical mastitis event).
In all models, random effects for multiple antimicrobial 
susceptibilities within isolates and isolates within herds were 
examined. Considering that very few cows contributed more than 
one isolate to the dataset (mean = 1.08 isolate/cow; range: 1–3), 
clustering at the cow level was not considered to have a sizeable 
effect on the model results. Similarly, only five quarters contrib-
uted more than one isolate to the dataset, thus, a random effect for 
quarter was not included. Pairwise correlation analysis was used 
to detect collinearity among the predictors. Unconditional asso-
ciations between the explanatory variables and the outcome were 
examined using simple univariable multilevel logistic regression, 
and variables with P values ≤0.20 were offered for inclusion in the 
multivariable models. A backwards stepwise procedure was used 
to determine the final models, and significance was declared at a 
P value ≤0.05. Excluded potentially confounding variables were 
reintroduced into the model and were retained if they changed 
the other model coefficients substantially (>20%). Once the final 
models were reached, the fit was evaluated by examination of 
residual plots (24). Intraclass correlation coefficients (ICCs) were 
calculated using the latent variable approximation to estimate 
the amount of clustering within herds and within isolates (24). 
Statistical analyses were performed using Stata IC 13.1 (25).
resUlTs
MalDi-ToF Mass spectrometry 
identification
The identification of streptococci isolates based on MALDI-ToF 
MS are listed in Table  1. Of the 296 isolates, 87.8% (260/296) 
had identification scores ≥2.0 and secure species identification; 
secure genus identification (score ≥1.7 to <2.0) was achieved for 
5.7% (17/296); no identification (score <1.7) was made for 1.7% 
(5/296) of the isolates. Difficulties in discrimination between spe-
cies were reported for 14 isolates (4.7%) that had scores ≥2.0 for 
two different species of Streptococci, thus these isolates could only 
be identified to the genus level. The four most common species 
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among the collection of other environmental streptococci (i.e., 
not S. uberis or S. dysgalactiae) were A. viridans, Enterococcus fae-
calis, Lactococcus garvieae, and Lactococcus lactis (Table 1). Two 
non-streptococci organisms were identified: an Arcanobacterium 
pluranimalium and a Staphylococcus chromogenes.
antimicrobial susceptibility
Only 8.2% (6/73) of Aerococcus spp. isolates were recovered in 
samples that had an SCC > 200,000 cells/mL and were subjected 
to MIC determination. A total of five isolates were excluded from 
susceptibility testing due to lack of MALDI-ToF identification 
and two were excluded because they were not environmental 
streptococci (A. pluranimalium and S. chromogenes). Of the 222 
isolates remaining, nine did not grow on the MIC plate after two 
attempts and were dropped from the analysis. The remaining 
213 isolates with MIC data were recovered from 177 individual 
cows. Nineteen cows had the same bacterial species identified in 
two separate samples and one cow had the same species identi-
fied in three separate samples. In these cases, only one isolate 
per species per cow was included in the final analysis. The 
selected 192 isolates were detected in 186 individual quarters. 
The number of isolates per herd (n = 18) ranged from 2 to 26, 
with a median of 9. The results of antimicrobial susceptibility 
testing of the 192 isolates are presented in Table  2. Results 
were aggregated into five categories: (1) S. uberis (n = 70), (2) 
S. dysgalactiae (n = 28), (3) other Streptococci spp. (including 
Aerococcus spp.; n = 35), (4) Lactococcus spp. (n = 32), and (5) 
Enterococcus spp. (n = 27).
Of all the antimicrobials considered, tetracycline displayed the 
smallest proportion of susceptible isolates. Greater than 90% of 
the isolates within each species group were sensitive to ceftiofur 
and penicillin/novobiocin; >80% of isolates were sensitive to 
cephalothin and erythromycin (Table 2). There was a wide range 
of susceptibility among the species groups to ampicillin, penicil-
lin, and pirlimycin.
Generally, S. dysgalactiae displayed the most susceptibility to 
the tested antimicrobials and 100% of the isolates were inhibited at 
the lowest concentration of ceftiofur, cephalothin, erythromycin, 
penicillin/novobiocin, and pirlimycin. The range of susceptibility 
for S. dysgalactiae was 17.8% (for tetracycline) to 100%, with a 
median of 100% (Table 2).
Isolates of S. uberis were less susceptible than S. dysgalactiae 
to all antimicrobials except for tetracycline. The proportion of 
susceptible S. uberis isolates ranged from 22.9% (for penicillin) 
to 98.6% (for penicillin/novobiocin), with a median of 82.2% 
(Table 2).
Isolates of other Streptococcus spp. were generally intermediate 
between S. uberis and S. dysgalactiae. All isolates were sensitive 
to cephalothin, penicillin/novobiocin, and pirlimycin. The range 
of susceptibility for other Streptococcus spp. was 42.9% (for 
tetracycline) to 100%, with a median percent susceptibility of 
91.5% (Table 2). Of the six isolates of Aerococcus spp., two were 
pansusceptible (susceptible to all the tested antimicrobials) and 
four were resistant to tetracycline (MIC > 4 μg/mL); two also dis-
played intermediate susceptibility to ceftiofur (MIC > 2 μg/mL), 
and another was intermediately susceptible to penicillin 
(MIC = 0.25 μg/mL).
Lactococcus spp. isolates were overall the least susceptible to 
the tested antimicrobials, with percent susceptibilities ranging 
from 0% (for penicillin) to 96.9% (for erythromycin), median 
75.1% (Table 2).
As a result of intrinsic resistance to cephalosporins, erythro-
mycin, and pirlimycin, and lack of breakpoint criteria for penicil-
lin/novobiocin, it is difficult to compare isolates of Enterococcus 
spp. to the other species. For the antimicrobials that were tested, 
the MIC50 and MIC90 were higher for Enterococcus spp. than for 
any of the other species (Table 2).
Two isolates of S. uberis and seven isolates of Streptococcus 
spp. were identified as resistant to erythromycin and sensitive to 
pirlimycin and were tested for inducible lincosamide resistance 
using the D-test. All isolates were negative.
At the isolate level, the proportion of antimicrobials to which 
an isolate was considered susceptible ranged from 12.5 to 100%, 
with a median of 87.5%. At the herd level, the proportion of 
susceptible isolates across all the antimicrobials ranged from 54.2 
to 91.6%, with a median of 81.4%.
logistic regression Models
Descriptive data for the cow and herd level variables considered 
in the models are presented in Table  3. Pairwise correlation 
analysis did not identify any potential issues with collinearity 
among the predictor variables. The results of the logistic model of 
susceptibility of all isolates except Enterococcus spp. against eight 
antimicrobials are presented in Table 4. The interaction between 
antimicrobial and species was significant, and a graphical display 
of the relationship is presented in Figure 1. Within-herd aver-
age SCC was significantly associated with susceptibility. When 
compared to a baseline of low SCC (<150,000 cells/mL), isolates 
recovered in herds with a high SCC were less likely to be suscep-
tible, but isolates from herds with a moderate SCC did not show 
a significant difference in susceptibility. The odds of susceptibility 
for isolates recovered in mid-lactation were higher, and the odds 
for isolates recovered in late lactation were lower when compared 
with isolates that were identified in early lactation cows. Based on 
the variance components, clustering at the isolate level was much 
greater than clustering at the herd level. The correlation among 
antimicrobial susceptibilities of two isolates from the same herd 
was lower (ICC = 0.02) than the correlation of the susceptibilities 
within an isolate (ICC = 0.26).
The results of the model of all isolates against three antimicro-
bials are presented in Table 5. The interaction between antimi-
crobial and species was significant, and a graphical display of the 
relationship is presented in Figure 2. Within-herd average SCC 
was significantly associated with susceptibility. When compared 
to a baseline of low SCC (<150,000 cells/mL), isolates recovered 
in herds with a moderate or high SCC were less likely to be sus-
ceptible to the tested antimicrobials. The effect of lactation stage 
did not meet the defined significance level but was considered 
borderline significant (P = 0.058). The observed trend was that 
the odds of being susceptible were higher for isolates recovered 
in mid-lactation and lower for isolates recovered in late lactation, 
when compared with isolates that were identified in early lactation 
cows. Based on the variance components, clustering at the isolate 
level was greater than clustering at the herd level. As such, the 
TaBle 2 | Distribution of minimum inhibitory concentrations (Mic) for Streptococcus uberis (n = 70), Streptococcus dysgalactiae (n = 28), 
Streptococcus spp.a (n = 35), Lactococcus spp.b (n = 32), and Enterococcus spp.c (n = 27) recovered from bovine milk samples.
Distribution (%) of Mic (g/ml)
antimicrobial species range n %susc.f 0.06 0.125 0.25 0.5 1 2 4 8 16 Mic50h Mic90i
Ampicillind S. uberis 0.06–4 70 71.4 14.3 5.7 51.4 22.9 0.0 1.4 4.3 0.25 0.5
S. dysgalactiae 0.06–4 28 100.0 92.9 3.6 3.6 0.0 0.0 0.0 0.0 ≤0.06 ≤0.06
Streptococcus spp. 0.06–4 35 91.5 62.9 22.9 5.7 0.0 8.6 0.0 0.0 ≤0.06 0.25
Lactococcus spp. 0.06–4 32 46.9 0.0 0.0 46.9 37.5 9.4 3.1 3.1 0.5 1
Enterococcus spp. 0.125–8 27 100.0 25.9 3.7 33.3 33.3 3.7 0.0 0.0 0.5 1
Ceftiofure S. uberis 0.25–2 70 98.5 21.4 20.0 51.4 5.7 1.4 1 1
S. dysgalactiae 0.25–2 28 100.0 100.0 0.0 0.0 0.0 ≤0.25 ≤0.25
Streptococcus spp. 0.25–2 35 91.4 65.7 14.3 11.4 0.0 8.6 ≤0.25 1
Lactococcus spp. 0.25–2 31 96.8 19.4 38.7 35.5 3.2 3.2 0.5 1
Cephalothind S. uberis 1–8 70 98.6 87.1 8.6 0.0 2.9 1.4 ≤1 2
S. dysgalactiae 1–8 28 100.0 100.0 0.0 0.0 0.0 ≤1 ≤1
Streptococcus spp. 1–8 35 100.0 97.1 2.9 0.0 0.0 ≤1 ≤1
Lactococcus spp. 1–8 32 81.3 0.0 21.9 37.5 21.9 18.8 4 >8
Erythromycind S. uberis 0.125–2 70 85.7 85.7 0.0 0.0 2.9 4.3 7.1 ≤0.125 2
S. dysgalactiae 0.125–2 28 100.0 100.0 0.0 0.0 0.0 0.0 ≤0.125 ≤0.125
Streptococcus spp. 0.125–2 35 85.8 82.9 2.9 0.0 8.6 0.0 5.7 ≤0.125 1
Lactococcus spp. 0.125–2 32 96.9 93.8 3.1 0.0 3.1 0.0 ≤0.125 ≤0.125
Penicillind S. uberis 0.06–4 70 22.9 14.3 8.6 44.3 24.3 2.9 0.0 2.9 2.9 0.25 0.5
S. dysgalactiae 0.06–4 28 92.9 89.3 3.6 7.1 0.0 0.0 0.0 0.0 ≤0.06 0.125
Streptococcus spp. 0.06–4 35 85.7 54.3 31.4 5.7 5.7 2.9 0.0 0.0 ≤0.06 0.25
Lactococcus spp. 0.06–4 32 0.0 0.0 0.0 3.1 50.0 40.6 0.0 3.1 3.1 0.5 1
Enterococcus spp. 0.125–8 27 100.0 25.9 0.0 0.0 3.7 63.0 3.7 3.7 2 2
Penicillin/
novobiocine
S. uberis 0.5/1–4/8 70 98.6 98.6 0.0 0.0 1.4 ≤0.5 ≤0.5
S. dysgalactiae 0.5/1–4/8 28 100.0 100.0 0.0 0.0 0.0 ≤0.5 ≤0.5
Streptococcus spp. 0.5/1–4/8 35 100.0 100.0 0.0 0.0 0.0 ≤0.5 ≤0.5
Lactococcus spp. 0.5/1–4/8 32 93.8 81.3 12.5 0.0 3.1 3.1 ≤0.5 1
Enterococcus spp. 1/2–8/16 27 NDg 96.3 3.7 0.0 0.0 ≤1 ≤1
Pirlimycine S. uberis 0.25–2 70 78.6 62.9 0.0 0.0 15.7 21.4 ≤0.25 >2
S. dysgalactiae 0.25–2 28 100.0 100.0 0.0 0.0 0.0 ≤0.25 ≤0.25
Streptococcus spp. 0.25–2 35 100.0 88.6 2.9 5.7 2.9 ≤0.25 0.5
Lactococcus spp. 0.25–2 32 40.6 18.8 18.8 3.1 0.0 59.4 >2 >2
Tetracyclined S. uberis 0.5–4 70 60.0 60.0 0.0 0.0 1.4 38.6 ≤0.5 >4
S. dysgalactiae 0.5–4 28 17.8 3.6 7.1 7.1 28.6 53.6 4 >4
Streptococcus spp. 0.5–4 35 42.9 34.3 5.7 2.9 8.6 48.6 >4 >4
Lactococcus spp. 0.5–4 32 68.8 59.4 9.4 0.0 6.3 25.0 ≤0.5 >4
Enterococcus spp. 1–8 27 37.0 37.0 0.0 0.0 0.0 63.0 >8 >8
Isolates with growth at the highest concentration tested are presented in the next highest concentration.
Vertical lines indicate CLSI (20, 23) breakpoints.
aStreptococcus spp. other than S. uberis, S. dysgalactiae, and S. agalactiae.
bL. lactis, L. garvieae.
cE. faecalis, E. saccharolyticus, E. faecium, E. pseudoavium, E. avium, E. casseliflavus, and E. hirae.
dInterpretive criteria based on human data.
eInterpretive criteria based on bovine mastitis data.
fPercent of susceptible isolates according to CLSI (20, 23).
gND, no interpretive criteria was available.
hThe MIC value that inhibits growth of 50% of the isolates.
iThe MIC value that inhibits growth of 90% of the isolates.
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correlation among susceptibilities within an isolate was greater 
(ICC = 0.26) than the correlation of susceptibilities between two 
different isolates (ICC = 0.06).
The breakdown of isolates among the three sample types 
was 44.8% (86/192) from apparently healthy lactating quarters, 
30.2% (58/192) from post-clinical mastitis, and 25.0% (48/192) 
collected post-calving. The results of the logistic model of suscep-
tibility considering sample type as the main independent variable 
are presented in Table 6. The odds of being susceptible was two 
times greater in isolates recovered in post-mastitis samples when 
TaBle 4 | Final multilevel logistic regression model of the susceptibilitya of 165 environmental streptococci isolates from bovine milk tested against 8 
antimicrobials.
β se(β) Or 95%ci (Or) P value Overall P value
intercept 1.26 0.48 – – – –
antimicrobial
Ampicillin 0.66 0.41 1.94 0.87 4.33 0.107
Ceftiofur 4.46 1.08 86.51 10.35 723.00 <0.001
Cephalothin 4.46 1.08 86.51 10.35 723.00 <0.001
Erythromycin 1.75 0.48 5.74 2.26 14.61 <0.001
Penicillin −2.11 0.44 0.12 0.05 0.29 <0.001
Pen/novobiocin 4.46 1.08 86.51 10.35 723.00 <0.001
Pirlimycin 1.14 0.43 3.14 1.34 7.34 0.008
Tetracycline Ref. – – – – –
species
Streptococcus uberis Ref. – – – – –
Streptococcus dysgalactiae −2.46 0.67 0.09 0.02 0.32 <0.001
Streptococcus spp.b −0.81 0.54 0.44 0.15 1.27 0.129
Lactococcus spp.c 0.06 0.59 1.06 0.33 3.38 0.917
antimicrobial x speciesd <0.001
herd somatic cell counte 0.002
≤150,000 cells/mL Ref. – – – – –
151,000–250,000 cells/mL −0.71 0.42 0.49 0.21 1.12 0.090
251,000–400,000 cells/mL −1.21 0.46 0.30 0.12 0.74 0.009
Days in milkf 0.034
0–100 Ref. – – – – –
101–200 0.78 0.35 2.19 1.09 4.38 0.027
201+ −0.69 0.33 0.50 0.26 0.96 0.036
Variance estimate se
Herd level 0.09 0.17
Isolate level 1.09 0.42
aSusceptible according to CLSI (20, 23).
bStreptococcus spp. other than S. uberis, S. dysgalactiae, and S. agalactiae.
cL. lactis and L. garvieae.
dInteraction term between antimicrobial and species.
eHerd somatic cell count = average within-herd somatic cell count from 2007 to 2008.
fDays in milk at the time of milk sample collection.
OR, odds ratio.
TaBle 3 | Descriptive statistics for cow and herd level factors considered in the analysis of the susceptibility of bovine intramammary infection-
associated environmental streptococci against eight antimicrobials.
Variable N % Minimum 25th percentile Median 75th percentile Maximum
lactation number
1 33 18.6 – – – – –
2 44 24.9 – – – – –
3 100 56.5 – – – – –
Stage of lactation at sample collection
Early (0–100 days in milk) 92 52.0 – – – – –
Mid (101–200 days in milk) 40 22.6 – – – – –
Late (201+ days in milk) 45 25.4 – – – – –
Lactating herd size – – 41 50 58 83 199
Mean days in milka – – 146 167 174 184 215
Mean 24 h milk production (kg)a – – 26 29 31 32 40
Mean somatic cell count (1,000 cells/mL)a – – 107 161 183 266 327
aWithin herd averages were calculated using data collected by the regional Dairy Herd Improvement agency over the course of the study period (2007 and 2008).
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compared with isolates recovered in non-clinical lactating quar-
ters; there was no significant difference in susceptibility between 
isolates recovered in post-calving samples and isolates recovered 
in normal lactational samples. There was no interaction between 
sample type and antimicrobial, and compared to the baseline of 
tetracycline, the odds of susceptibility was significantly greater 
for all antimicrobials except for penicillin, which was not sig-
nificantly different from tetracycline. As with the previous two 
FigUre 1 | Predicted probability of antimicrobial susceptibility for isolates of environmental streptococci, excluding Enterococcus spp., against 
eight antimicrobials. Presented estimates are for isolates recovered from cows in early lactation (0–100 days in milk) and from herds with a low within-herd 
average somatic cell count (<150,000 cells/mL). amp, ampicillin; xnl, ceftiofur; cep, cephapirin; ery, erythromycin; pen, penicillin; pnov, penicillin + novobiocin; pirl, 
pirlimycin; tet, tetracycline.
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models, correlation between the antimicrobial susceptibilities 
was greater within a single isolate (ICC = 0.23) than between two 
different isolates from the same herd (ICC = 0.04).
DiscUssiOn
Determination of antimicrobial susceptibility of bovine mastitis 
pathogens via broth microdilution produces a quantitative result 
(the MIC) that can be used to compare data from various stud-
ies, either from different regions of the world or from the same 
region across different points in time. From a clinical perspec-
tive, classifying bacterial isolates as susceptible, intermediate, or 
resistant based on their MIC to a particular antimicrobial helps 
to guide treatment decisions. Clinical breakpoints for a particular 
antimicrobial are dependent upon the species of bacteria, the tis-
sue or organ that is infected, and the host species. With regards 
to bovine mastitis pathogens, CLSI provides interpretive criteria 
for only three antimicrobials (ceftiofur, penicillin/novobiocin, 
and pirlimycin) against four or five pathogens [S. aureus, S. aga-
lactiae, S. dysgalactiae, S. uberis, and E. coli (for ceftiofur only)]. 
Therefore, for other combinations of antimicrobial and pathogen, 
researchers and practitioners are required to use breakpoints 
derived from human data (20, 23). The appropriateness of apply-
ing these non-specific breakpoints is questionable but is, in most 
cases, the best available approach.
The results of this research support continued susceptibility of 
environmental streptococci to beta-lactam antimicrobials. This 
is in agreement with reports from other areas of North America, 
Europe, New Zealand, and South America (11, 12, 14, 15, 26–28). 
Beta-lactams are considered the first line of defense against 
environmental streptococci and are widely used in Canada. 
According to Saini et al. (3), regarding intramammary product 
usage in Canada, overall and, in the Maritime region specifically, 
penicillin + novobiocin was used most frequently, followed by 
penicillin, and first generation cephalosporins. Despite high 
usage rates of penicillin + novobiocin, 97.9% (188/192) of the iso-
lates tested in this study had an MIC ≤ 0.5 μg/mL (or ≤1 μg/mL 
for Enterococcus spp.) that is below the ≤1 μg/mL cut point for 
susceptibility defined for S. dysgalactiae and S. uberis. Regarding 
cephalothin, the first generation cephalosporin included in this 
study, 95.8% (158/165) of the isolates were considered susceptible, 
and all species except for Lactococcus spp. had MIC50 and MIC90 
≤2 μg/mL, while the breakpoint for susceptibility for Streptococci 
spp. is set at ≤4 μg/mL.
A noteworthy departure from the expected susceptibility 
of environmental streptococci to beta-lactams was the appar-
ent reduced susceptibility of S. uberis to penicillin and to a 
lesser degree, ampicillin. While the majority of studies from 
around the world report MIC50 of 0.03–0.06  μg/mL, MIC90 
of 0.06–0.25  μg/mL, and susceptibilities ≥95% (12, 29–32), 
reduced susceptibility of S. uberis appears to be a sporadically 
occurring phenomenon with occasional reports in the literature 
(13). According to Rossitto et al. (33), in a study of 133 S. uberis 
isolates recovered from cases of bovine mastitis in California 
from 1997 to 1999, only 50.4% were considered susceptible, 
with an MIC50 and MIC90 of 0.25  μg/mL. More recently, in 
TaBle 5 | Final multilevel logistic regression model of the susceptibilitya of 192 environmental streptococci isolates from bovine milk tested against 3 
antimicrobials.
β se(β) Or 95%ci(Or) P value Overall P value
intercept 1.43 0.55 – – – –
antimicrobial
Ampicillin 0.66 0.41 1.93 0.86 4.32 0.111
Penicillin −2.08 0.46 0.12 0.05 0.31 <0.001
Tetracycline Ref. – – – – –
species
Streptococcus uberis Ref. – – – – –
Streptococcus dysgalactiae  −2.41 0.68 0.09 0.02 0.34 <0.001
Streptococcus spp.b −0.89 0.54 0.41 0.14 1.17 0.095
Lactococcus spp.c −0.05 0.58 0.95 0.31 2.94 0.925
Enterococcus spp.d −1.42 0.61 0.24 0.07 0.81 0.021
antimicrobial × speciese <0.001
herd somatic cell countf 0.033
≤150,000 cells/mL Ref. – – – – –
151,000–250,000 cells/mL −1.01 0.52 0.36 0.13 1.01 0.052
251,000–400,000 cells/mL −1.52 0.59 0.22 0.07 0.69 0.010
Days in milkg 0.058
0–100 Ref. – – – – –
101–200 0.68 0.38 1.97 0.94 4.14 0.072
201+ −0.39 0.37 0.68 0.33 1.39 0.290
Variance estimate se
Herd level 0.27 0.25
Isolate level 0.90 0.58
aSusceptible according to CLSI (20, 23).
bStreptococcus spp. other than S. uberis, S. dysgalactiae, and S. agalactiae.
cL. lactis and L. garvieae.
dE. faecalis, E. saccharolyticus, E. faecium, E. pseudoavium, E. avium, E. casseliflavus, and E. hirae.
eInteraction term between antimicrobial and species.
fHerd somatic cell count = average within herd somatic cell count from 2007 to 2008.
gDays in milk at the time of milk sample collection.
OR, odds ratio.
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separate studies from New Zealand and Europe, both reported 
MIC50 of 0.03  μg/mL and MIC90 of 0.25  μg/mL with similar 
distribution of susceptibility to the current study, with 68.6 or 
70.2% of isolates considered susceptible, 30.4 or 29.8% inter-
mediate, and 1 or 0% resistant, respectively (14, 15). Finally, 
in the United States, a longitudinal study of antimicrobial 
susceptibility of mastitis pathogens detected a linear trend of 
decreasing susceptibility of S. uberis to penicillin; however, 
the within year range of susceptible isolates was much higher 
than in the current study, from 86.2 to 98.4% (34). The major-
ity of isolates of S. uberis tested in the current study, classified 
as non-susceptible, had an MIC of only one or two dilutions 
above the intermediate susceptibility breakpoint. These findings 
support the results of Haenni et al. (13) who described a shift 
toward penicillin resistance among a subpopulation of S. uberis 
isolates and also identified the presence of resistance-associated 
mutations among isolates considered intermediately susceptible 
to penicillin. In the present study, four S. uberis isolates were 
considered resistant to penicillin with an MIC of ≥4.0 μg/mL; 
these isolates were also the outliers for ampicillin with MIC 
of 2–4 μg/mL. To the authors’ knowledge, MIC ≥  4.0 against 
penicillin for S. uberis are very rarely reported in the literature. 
In a follow-up study, a subset of S. uberis and S. dysgalactiae 
isolates will be sequenced using next-generation sequencing to 
identify AMR genes and virulence factors, and to examine the 
relationship to the phenotypic expression of AMR.
Susceptibility to tetracycline was low for all species, and 
reduced susceptibility of environmental streptococci to tetra-
cycline is frequently reported in the literature (12, 28, 30, 35, 
36). Tetracyclines have been used extensively to treat many 
types of infections in both humans and animals for numerous 
years (37, 38). Many of the genetic determinants of tetracycline 
resistance have been shown to be actively transferred between 
bacterial genera and between hosts, both human and animal, 
and as a result, resistance to tetracycline is found in almost all 
bacterial genera (37). Furthermore, the persistence of tetracycline 
resistance genes in the apparent absence of selective pressure via 
exposure to treatment with tetracycline has been reported (37). 
Thus, although tetracycline has limited distribution in the udder 
and is not commonly used to treat intramammary infections (39), 
resistance to tetracycline among the isolates in the current study 
was not unexpected.
TaBle 6 | Final multilevel logistic regression model of the susceptibilitya of 192 environmental streptococci isolates from bovine milk tested against 8 
antimicrobials with focus on the effect of sample type.
β se(β) Or 95%ci (Or) P value Overall P value
intercept  −0.33 0.24 – – – –
antimicrobial <0.001
Ampicillin 1.66 0.26 5.24 3.17 8.67 <0.001
Ceftiofur 4.08 0.51 58.88 21.54 160.97 <0.001
Cephalothin 3.72 0.45 41.15 17.01 99.55 <0.001
Erythromycin 2.75 0.34 15.58 8.03 30.26 <0.001
Penicillin 0.13 0.23 1.14 0.73 1.76 0.57
Pen/novo 4.64 0.63 103.30 29.86 357.37 <0.001
Pirlimycin 1.74 0.27 5.65 3.30 9.65 <0.001
Tetracycline Ref. – – – – –
sample type 0.021
Lactationalb Ref. – – – – –
Post-mastitisc 0.73 0.26 2.07 1.24 3.46 0.006
Post-calvingd 0.26 0.27 1.29 0.77 2.18 0.33
Variance estimate se
Herd level 0.18 0.15
Isolate level 0.77 0.26
aSusceptible according to CLSI (20, 23).
bIsolates recovered in lactational and pre-dry-off milk samples.
cIsolates recovered in samples collected between 2 and 5 weeks after a recorded clinical mastitis event.
dIsolates recovered in samples collected between 0 and 14 days in milk.
OR, odds ratio.
FigUre 2 | Predicted probability of antimicrobial susceptibility for isolates of environmental streptococci, including Enterococcus spp., against 
three antimicrobials. Presented estimates are for isolates recovered from cows in early lactation (0–100 days in milk) and from herds with a low within-herd 
average somatic cell count (<150,000 cells/mL). amp, ampicillin; pen, penicillin; tet, tetracycline.
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According to the results of the current study, there were dif-
ferences in antimicrobial susceptibility between the genera and 
between S. uberis and S. dysgalactiae. This highlights the impor-
tance of obtaining the most detailed diagnosis possible when 
formulating treatment protocols. In the present study, isolates 
of S. uberis displayed lower susceptibility and higher MIC than 
isolates of S. dysgalactiae, with the exception of tetracycline. This 
has been reported by others (12, 32, 35) and is also reflected by 
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the differences in treatment protocols recommended for these 
pathogens. While cure risk for S. dysgalactiae following a stand-
ard course of treatment is high, extended therapy is required to 
achieve similar cure risk for S. uberis infections (40–42).
Until recently, isolates of Lactococcus spp. and Enterococcus 
spp. were commonly identified as other streptococci (7), but, 
with the application of MALDI-ToF MS, accurate and easy 
speciation of numerous members of other environmental 
streptococci is now possible (43, 44). According to this study, 
important differences between susceptibility of Lactococcus spp. 
compared with the species of Streptococcus were highlighted, 
most notably higher MICs for pirlimycin and cephalothin. 
Pirlimycin is an analog to clindamycin, and clindamycin resist-
ance has been proposed to be intrinsic in L. gariveae (45). In this 
study, all L. gariveae isolates (n = 16) had MIC > 2 μg/mL for 
pirlimycin, compared to L. lactis isolates of which 80% (12/15) 
had MIC ≤ 0.5 μg/mL and only two had an MIC > 2 μg/mL. 
The same species difference but against clindamycin have been 
reported by others (45–47), and similar results of L. lactis 
against pirlimycin have also been reported (7). For cephalothin, 
the MIC for Lactococcus spp. overall was higher than the other 
species, and a different MIC profile between L. lactis and 
L. gariveae was observed here as well and has been described 
by others (45–47). For L. gariveae, the MIC were all ≥4 μg/mL; 
for L. lactis, all but two outliers had an MIC ≤ 4 μg/mL, and 
the outliers had an MIC > 8 μg/mL. Lacking CLSI interpretive 
criteria for Lactococcus spp., we extrapolated breakpoints from 
the Streptococcus spp. This may have resulted in misclassifying 
isolates of Lactococcus spp. as susceptible or non-susceptible 
and thus affecting our interpretation of the results. This high-
lights the need for the development of additional bovine IMI-
associated interpretive criteria for Lactococcus spp. and other 
bovine mastitis pathogens.
Intrinsic resistance of Enterococcus spp. to numerous anti-
microbials is another example of how treatment failures might 
occur if causative pathogen diagnosis does not go beyond the 
group level. The MICs for Enterococcus spp. for ampicillin, peni-
cillin, and tetracycline were higher than for the other species 
but were similar to those reported in data from other countries 
(29, 33, 48, 49). A clear bimodal distribution was observed 
toward tetracycline, which has been reported by others (33). 
This trend did not appear to be species-dependent as the spe-
cies making up the genus group were present in both low and 
high MIC values. To a lesser degree, the Enterococcus spp. also 
appeared to have a bimodal MIC distribution for penicillin. 
Upon closer inspection, all isolates with MIC ≤ 0.125 μg/mL 
were E. saccharolyticus. These isolates also made up the group 
of Enterococcus spp. with an MIC ≤  0.125 for ampicillin. To 
the authors’ knowledge, MIC data for E. saccharolyticus have, 
yet, to be reported. The majority of the remaining isolates of 
Enterococcus spp. had an MIC of 2 μg/mL for penicillin and 
0.5–1 μg/mL for ampicillin.
According to the results of the logistic regression models, 
susceptibility was inversely related to herd level SCC such 
that isolates recovered in herds with moderate or high within-
herd average SCC were less likely to be susceptible to the 
tested antimicrobials than isolates recovered in herds with 
low within-herd SCC. Considering that SCC is an indicator 
of udder health, it is logical to hypothesize that herds with a 
higher average SCC will have more IMI and will use antimicro-
bials more frequently than herds with a lower SCC. Exposure 
to antimicrobials is considered a driving force for AMR, thus 
herds using more antimicrobials could be expected to have 
reduced susceptibility among the bacteria isolated on the farm 
that on farms with low antimicrobial usage rates. A direct 
relationship between herd-level SCC and antimicrobial usage 
has not been supported by the current literature, but previous 
studies have reported that a more in-depth investigation in this 
area is required (3, 50). A second hypothesis explaining this 
association is the potential linkage between AMR and viru-
lence (in this case, manifested as increased SCC). If the genetic 
determinants for pathogenicity and resistance are present on 
the same genetic element, or if a single genetic determinant 
confers both virulence and resistance, then both AMR and 
bacterial virulence will be coselected under the right selection 
pressures (51). To the authors’ knowledge, this phenomenon 
has not been explored among the streptococci associated with 
bovine IMI and requires further study.
Another interesting finding of the logistic models is that 
antimicrobial susceptibility was associated with stage of 
lactation of the host. Our results suggest that environmental 
streptococci isolated from cows in mid-lactation are more 
susceptible and conversely, isolates recovered in cows in late 
lactation are less susceptible when compared to the baseline 
of environmental streptococci identified in cows in early lac-
tation. Blanket application of intramammary antimicrobials 
(dry cow therapy) at the end of lactation is common in North 
America and was employed as a mastitis control procedure in 
an estimated 88% of herds in 2007–2008 (52). Therefore, iso-
lates recovered in the post-calving period were likely to have 
had recent exposure to antimicrobials. However, this study is 
neither able to determine if the IMI recovered post-calving 
were acquired in the dry period nor to determine if reduced 
susceptibility might have occurred as a result of either acquired 
resistance or elimination of a susceptible population by the dry 
cow therapy. Antimicrobial treatment in mid-lactation, at the 
time of peak milk production, is often disadvantageous from 
an economic perspective considering the cost of discarded 
milk due to antimicrobial residues (53). As a result, farmers 
might preferentially chose non-antimicrobial alternatives for 
the treatment of clinical mastitis (i.e., massage of the udder 
and frequent milking to flush out the infection) when cases 
arise during this high production stage of the lactation cycle. 
The prevalence of chronic IMI increases with increasing DIM 
(31), and this chronicity can be attributed in part to reduced 
susceptibility to antimicrobial treatment, thus it is not surpris-
ing to observe reduced susceptibility among the environmental 
streptococci recovered in late lactation.
Finally, according to the model including sample type, environ-
mental streptococci isolated from post-clinical mastitis samples 
were more susceptible than isolates recovered from non-clinical 
lactating quarters. This apparent association is contrary to the 
principle that antimicrobial use propagates resistance and differs 
from Saini et al. (19), who concluded that there was no detectable 
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difference in resistance proportion among isolates of S. aureus, E. 
coli, and Klebsiella spp. collected from intramammary infection, 
subclinical mastitis, and clinical mastitis cases. For the analysis 
of susceptibility, isolates originating from post-mastitis samples 
were preferentially chosen if more than one isolate of a species 
was recovered from an individual cow. It was our expectation that 
isolates recovered in milk samples collected post-mastitis would 
represent bacteria that failed to be eliminated in response to 
antimicrobial treatment and thus display reduced susceptibility. 
Unfortunately, animal-level treatment information was not avail-
able. The bacteria recovered in the samples collected at the time 
of mastitis diagnosis were not characterized by MALDI-ToF MS 
but rather were identified as S. uberis, S. dysgalactiae, and other 
Streptococci spp. based on traditional phenotypic and biochemi-
cal analysis. Based on this initial classification, in 50% (29/58) of 
cases had the same species (S. uberis or S. dysgalactiae) or group 
(other Streptococci spp.) identified at the time of diagnosis and in 
the subsequent sample. Without strain-typing of the pathogens 
causing the initial case of clinical mastitis and recovered in follow-
up samples, it is impossible to determine if the isolates recovered 
in the period of 2–5 weeks after the onset of disease represented 
a persistent infection or a new intramammary infection. Based 
on the results of the current study, it is likely that, in cases treated 
with one of the commonly used beta-lactam antimicrobials, the 
infection was eliminated and the bacteria recovered post-mastitis 
represented a new infection.
In all three multilevel logistic models, the ICC at the isolate 
level was greater than at the herd level, indicating that most of the 
unexplained variation in antimicrobial susceptibility was within 
individual bacterial isolates (or cows). This suggests that the 
patterns of susceptibility were similar across all 18 farms (range: 
54–92%; median = 81%) and thus susceptibility to antimicrobials 
among environmental pathogens is of importance to all farms 
experiencing environmental streptococcal intramammary 
infection. This also highlights the importance of obtaining the 
most detailed diagnosis possible, including both bacteriological 
culture and antimicrobial sensitivity testing, when formulating 
treatment protocols. Furthermore, interpretive criteria specific 
to bovine mastitis pathogens are scarce, and there is a need for 
the development of additional bovine IMI-associated interpretive 
criteria.
cOnclUsiOn
The results of this study support continued susceptibility 
of  envi ronmental streptococci to beta-lactam antimicrobials. 
A noteworthy departure from the expected susceptibility of envi-
ronmental streptococci to beta-lactams was the apparent reduced 
susceptibility of S. uberis to penicillin. According to the results of 
the current study, there were differences in antimicrobial suscepti-
bility between the genera and between S. uberis and S. dysgalactiae; 
however, susceptibility to tetracycline was low for all species.
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